A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness

StatusEnrolling by Invitation
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Enrolling by Invitation Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Site details revised
    • Publications: details revised at 11 of 11 entries
  2. Start date changed from estimate of Mar 2026 to Mar 23, 2026
    • Eligibility criteria expanded, about 8 words
    v2
  3. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,024 trials monitored
See 128 trials at risk
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).
Trial Details
NCT Number NCT07420803
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Chronic Dizziness, Persistent Postural Perceptual Dizziness
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov